Skip to main content
. 2021 Jan 28;8:611149. doi: 10.3389/fbioe.2020.611149

Table 1.

Demographics and clinical examinations in PAH and normal control subjects**.

Variables Control (n = 5) PAH (n = 6) P value
Demographics
Age, years 51 ± 15 50 ± 11 0.792
Gender, male/female 1/5 1/4 0.727
Weight, kg 66 ± 18 61 ± 10 0.662
Height, cm 160 ± 8 162 ± 6 0.792
Clinical Exam
Body surface area, m2 1.70 ± 0.26 1.65 ± 0.12 0.931
Body mass index, kg/m2 25.2 ± 4.3 23.2 ± 4.7 0.177
6-min walking test, m 391 ± 103
NYHA functional class I, n 1
NYHA functional class II, n 4
NYHA functional class III, n 1
NYHA functional class IIII, n 0
Cardiac magnetic resonance
LV ejection fraction, % 64 ± 6 60 ± 8 0.329
LVEDV, ml 111 ± 15 113 ± 18 0.931
LVESV, ml 40 ± 8 46 ± 14 0.792
LVSV, ml 71 ± 11 67 ± 12 0.537
RV ejection fraction, % 60 ± 9 45 ± 17 0.177
RVEDV, ml 118 ± 24 189 ± 114 0.537
RVESV, ml 49 ± 18 119 ± 104 0.329
RVSV, ml 69 ± 12 71 ± 16 0.931
Hemodynamics
Heart rate, bpm 81 ± 17 71 ± 16 1
Diastolic blood pressure, mmHg 80 ± 17 74 ± 10 0.792
Systolic blood pressure, mmHg 137 ± 21 130 ± 30 0.537
Cardiac output, l/min 5.01 ± 3.32
Cardiac index, l/min/m2 2.98 ± 1.64
Right atrial pressure, mmHg 6 ± 6
Mean pulmonary artery pressure, mmHg 38 ± 8
Pulmonary capillary wedge pressure, mmHg 12 ± 1
Systemic vascular resistance, dyne s/cm5 1,948 ± 750
Total pulmonary vascular resistance, dyne s/cm5 588 ± 228
Pulmonary systemic flow ratio 0.98 ± 0.12
Pulmonary and systemic resistance ratio 0.33 ± 0.11
**

Cohort is a subset from a previous analysis (Finsberg et al., 2019). LV, left ventricle; LVEDV, left ventricle end-diastolic volume; LVESV, left ventricle end-systolic volume; LVSV, left ventricle stroke volume; RV, right ventricle; LVEDV, right ventricle end-diastolic volume; LVESV, right ventricle end-systolic volume; LVSV, right ventricle stroke volume.